El Vínculo El Vínculo.
Closed European Union Services

IIT study CLEAR "Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)"

Buyer: Universitätsklinikum Münster

Published
22 October 2024
Submission deadline
21 November 2024, 12:00
Place of performance
Münster, DEA33
Procedure
Open procedure
Lots
1
Documents
1
Notice number
00639713-2024
Reference
39ab6b8e-72b1-4b74-a130-c35aecca2c19
Official source
Official source

CPV codes

Description

The IIT (Investigator Initiated Trial) study CLEAR "Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)" should take place in 26 trial sites in Germany and 4 trial sites in Italy. The University of Münster acts as sponsor of the clinical trial CLEAR according to Article 2 No. 14 Regulation (EU) 536/2014 (CTR). For the conduct of the study in Italy, we would like to transfer the following tasks in the areas of project management, trial start-up, monitoring and quality assurance to another institution in Italy. A synopsis of the study is attached to this tender as Appendix 1. A framework agreement will be concluded afterwards.

Official publications

Other tenders from Universitätsklinikum Münster

Frequently asked questions

What is the deadline to bid for this tender?
The submission deadline is 21 November 2024, 12:00. Check the official source, as dates can be modified.
Who is the buyer of this tender?
The contracting authority is Universitätsklinikum Münster (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.